Zurich Cantonal Bank
IMCR icon

Zurich Cantonal Bank’s Immunocore IMCR Stock Holding History

Zurich Cantonal Bank’s Portfolio IMCR Stock Details IMCR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-201
Closed -$5.93K – 2655
2024
Q4 		$5.93K Sell
201
-43
-18% -$1.36K ﹤0.01% 2616
2024
Q3 		$7.6K Sell
244
-4
-2% -$145 ﹤0.01% 2625
2024
Q2 		$8.4K Sell
248
-6
-2% -$306 ﹤0.01% 2623
2024
Q1 		$16.5K Buy
254
+11
+5% +$755 ﹤0.01% 2639
2023
Q4 		$16.6K Sell
243
-30
-11% -$1.56K ﹤0.01% 2662
2023
Q3 		$14.2K Sell
273
-89
-25% -$5.27K ﹤0.01% 2723
2023
Q2 		$21.7K Sell
362
-70
-16% -$4K ﹤0.01% 2713
2023
Q1 		$21.4K Buy
+432
New +$24.3K ﹤0.01% 2742
2022
Q3 		– Sell
-3,864
Closed -$144K – 2914
2022
Q2 		$144K Hold
3,864
– – ﹤0.01% 1987
2022
Q1 		$116K Hold
3,864
– – ﹤0.01% 2223
2021
Q4 		$132K Hold
3,864
– – ﹤0.01% 2355
2021
Q3 		$143K Hold
3,864
– – ﹤0.01% 2126
2021
Q2 		$151K Buy
+3,864
New +$149K ﹤0.01% 2002

Other funds holding IMCR

T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.62B AUM 138.67% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return

Zurich Cantonal Bank's IMCR Position: Q1 2025 in Review

Zurich Cantonal Bank sold out of Immunocore (IMCR) in Q1 2025, closing a stake of 201 shares — an estimated $5.93K sold.

Zurich Cantonal Bank first reported a position in IMCR in Q2 2021 and held it in 13 quarters. The position peaked at $151K in Q2 2021. 116 funds tracked by Wall St. Rank hold IMCR as of Q1 2025.

  • Zurich Cantonal Bank reported no remaining Immunocore position as of Q1 2025 after selling out during the quarter.
  • Zurich Cantonal Bank sold 201 Immunocore shares in Q1 2025, an estimated $5.93K.
  • Zurich Cantonal Bank first reported a position in Immunocore in Q2 2021 and held it in 13 quarters.
  • Zurich Cantonal Bank's Immunocore position peaked at $151K in Q2 2021.
  • 116 funds tracked by Wall St. Rank held Immunocore as of Q1 2025.

Based on Zurich Cantonal Bank's 13F filing for Q1 2025, filed 7 May 2025.